DP
NVO

Diadema Partners’s Novo Nordisk NVO Stock Holding History

Diadema Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100,000
Closed -$6.9M – 152
2025
Q2 		$6.9M Sell
100,000
-8,700
-8% -$592K 2.1% 15
2025
Q1 		$7.55M Buy
+108,700
New +$8.98M 1.97% 16

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Diadema Partners's NVO Position: Q1 2026 in Review

Diadema Partners opened a new position in Novo Nordisk (NVO) in Q1 2026: 14,577 shares worth $521K. The stake represents 0.09% of the portfolio and ranks #107 among its holdings. This is a return to the name: Diadema Partners previously reported a position in NVO as recently as Q3 2025.

Diadema Partners first reported a position in NVO in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.68M in Q1 2025. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Diadema Partners held 14,577 shares of Novo Nordisk worth $521K as of Q1 2026.
  • Novo Nordisk was a new Diadema Partners position in Q1 2026.
  • Novo Nordisk made up 0.09% of Diadema Partners's portfolio in Q1 2026, its #107 holding.
  • Diadema Partners first reported a position in Novo Nordisk in Q1 2025 and has held it in 3 quarters since.
  • Diadema Partners's Novo Nordisk position peaked at $1.68M in Q1 2025.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Diadema Partners's 13F filing for Q1 2026, filed 15 May 2026.